The Effects of Hyperbaric Oxygen Therapy (HBOT) on Acute Thermal Burns

S

Singapore Health Services (SingHealth)

Status and phase

Unknown
Phase 1

Conditions

Acute Thermal Burns

Treatments

Other: Standard care
Procedure: Hyperbaric Oxygen Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT00824551
1501

Details and patient eligibility

About

The blinded RCTstudy aims to: * Determine the effects of HBOT on burns conversion for patients who have fresh thermal burns injury using the LDI. * Objectively determine the proportion of burns conversion in areas of partial thickness burns for early thermal burns injury in both arms of the RCT. * Study the effects of HBOT on immunological markers IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α and TGF-β ( comparison between both arms and 2 assessment points). * Study the effect of HBOT on haematological markers including procalcitonin ,albumin, lymphocyte counts, neutrophil count, and macrophage count. * Study the effects of HBOT on histology specimens in quantifying P53 protein, leukocyte and macrophage infiltration, burns depth assessment and vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) . * Study the effects of HBOT on bacteriology of tissue culture in areas of deep dermal burns.

Enrollment

80 estimated patients

Sex

All

Ages

21 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Thermal burns injury less than 40% with areas of deep dermal/ full thickness burns.
  • Less than 24 hours from time of injury.
  • No inhalational injury (Nasoendoscopy and bronchoscopic diagnosis by burns centre medical team/ department of emergency medicine in SGH).
  • Age 21 years old and above and less than 60 years old.
  • Not intubated and not on inotropic support.
  • Understands and agrees to informed consent (approved by IRB SGH).

Exclusion criteria

  • Untreated pneumothorax
  • Medications: Bleomycin, Cis-platin, Doxorubicin, Disulfiram (Chemotherapy)
  • Acute uncontrolled medical condition or significant medical condition (eg. Cerebrovascular accident, diabetic ketoacidosis, severe hypertensive 180/ 110 mmHg, end stage renal failure, chest pain, bleeding gastrointestinal tract, coma and acute asthma attack)
  • Other surgical emergencies (eg. open fractures, compartment syndrome and acute abdomen)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Hyperbaric Oxygen Therapy
Experimental group
Description:
2 HBOT treatments
Treatment:
Procedure: Hyperbaric Oxygen Therapy
2
Active Comparator group
Description:
Standard care and treatment
Treatment:
Other: Standard care

Trial contacts and locations

1

Loading...

Central trial contact

chong si jack

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems